These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 25595899)

  • 21. Epidermal growth factor-induced modulation of cytokeratin expression levels influences the morphological phenotype of head and neck squamous cell carcinoma cells.
    Makarova G; Bette M; Schmidt A; Jacob R; Cai C; Rodepeter F; Betz T; Sitterberg J; Bakowsky U; Moll R; Neff A; Sesterhenn A; Teymoortash A; Ocker M; Werner JA; Mandic R
    Cell Tissue Res; 2013 Jan; 351(1):59-72. PubMed ID: 23111772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. JunB promotes cell invasion, migration and distant metastasis of head and neck squamous cell carcinoma.
    Hyakusoku H; Sano D; Takahashi H; Hatano T; Isono Y; Shimada S; Ito Y; Myers JN; Oridate N
    J Exp Clin Cancer Res; 2016 Jan; 35():6. PubMed ID: 26754630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines.
    Bancroft CC; Chen Z; Yeh J; Sunwoo JB; Yeh NT; Jackson S; Jackson C; Van Waes C
    Int J Cancer; 2002 Jun; 99(4):538-48. PubMed ID: 11992543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD73 is associated with poor prognosis in HNSCC.
    Ren ZH; Lin CZ; Cao W; Yang R; Lu W; Liu ZQ; Chen YM; Yang X; Tian Z; Wang LZ; Li J; Wang X; Chen WT; Ji T; Zhang CP
    Oncotarget; 2016 Sep; 7(38):61690-61702. PubMed ID: 27557512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of cyclooxygenase-1 expression on the efficacy of cyclooxygenase-2 inhibition in head and neck squamous cell carcinoma cell lines.
    Park SW; Kim HS; Choi MS; Kim JE; Jeong WJ; Heo DS; Sung MW
    Anticancer Drugs; 2011 Jun; 22(5):416-23. PubMed ID: 21301321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin.
    Zuo JH; Zhu W; Li MY; Li XH; Yi H; Zeng GQ; Wan XX; He QY; Li JH; Qu JQ; Chen Y; Xiao ZQ
    J Cell Biochem; 2011 Sep; 112(9):2508-17. PubMed ID: 21557297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of DDR2 contributes to cell invasion and migration in head and neck squamous cell carcinoma.
    Xu J; Lu W; Zhang S; Zhu C; Ren T; Zhu T; Zhao H; Liu Y; Su J
    Cancer Biol Ther; 2014 May; 15(5):612-22. PubMed ID: 24556606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual-receptor (EGFR and c-MET) inhibition by tumor-suppressive miR-1 and miR-206 in head and neck squamous cell carcinoma.
    Koshizuka K; Hanazawa T; Fukumoto I; Kikkawa N; Matsushita R; Mataki H; Mizuno K; Okamoto Y; Seki N
    J Hum Genet; 2017 Jan; 62(1):113-121. PubMed ID: 27169691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional Role of DUSP6 in the EGFR-mediated Progression of Head and Neck Squamous Cell Carcinoma.
    Tai CH; Wang CC; Shih YC; Chen YJ; Chen BK; Chen LC
    Anticancer Res; 2024 Jun; 44(6):2545-2554. PubMed ID: 38821599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osteoactivin regulates head and neck squamous cell carcinoma invasion by modulating matrix metalloproteases.
    Arosarena OA; Barr EW; Thorpe R; Yankey H; Tarr JT; Safadi FF
    J Cell Physiol; 2018 Jan; 233(1):409-421. PubMed ID: 28295306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypoxia induces TFE3 expression in head and neck squamous cell carcinoma.
    Sun ZJ; Yu GT; Huang CF; Bu LL; Liu JF; Ma SR; Zhang WF; Liu B; Zhang L
    Oncotarget; 2016 Mar; 7(10):11651-63. PubMed ID: 26872381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A multiplicity of anti-invasive effects of farnesyl transferase inhibitor SCH66336 in human head and neck cancer.
    Oh SH; Kang JH; Kyu Woo J; Lee OH; Kim ES; Lee HY
    Int J Cancer; 2012 Aug; 131(3):537-47. PubMed ID: 22113431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of c-erbB receptors, MMPs and VEGF in squamous cell carcinoma of the head and neck.
    Do NY; Lim SC; Im TS
    Oncol Rep; 2004 Aug; 12(2):229-37. PubMed ID: 15254682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cetuximab sensitivity of head and neck squamous cell carcinoma xenografts is associated with treatment-induced reduction in EGFR, pEGFR, and pSrc.
    Jedlinski A; Garvin S; Johansson AC; Edqvist PH; Ponten F; Roberg K
    J Oral Pathol Med; 2017 Oct; 46(9):717-724. PubMed ID: 28036101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Up-regulation of HB-EGF by the COX-2/PGE2 signaling associates with the cisplatin resistance and tumor recurrence of advanced HNSCC.
    Yang CC; Tu HF; Wu CH; Chang HC; Chiang WF; Shih NC; Lee YS; Kao SY; Chang KW
    Oral Oncol; 2016 May; 56():54-61. PubMed ID: 27086487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistent activation of Rac1 in squamous carcinomas of the head and neck: evidence for an EGFR/Vav2 signaling axis involved in cell invasion.
    Patel V; Rosenfeldt HM; Lyons R; Servitja JM; Bustelo XR; Siroff M; Gutkind JS
    Carcinogenesis; 2007 Jun; 28(6):1145-52. PubMed ID: 17234718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early Growth Response 1-Dependent Downregulation of Matrix Metalloproteinase 9 and Mouse Double Minute 2 Attenuates Head and Neck Squamous Cell Carcinoma Metastasis.
    Kim J; Kang SM; Oh SY; Kang SH; Lee I; Hwang JC; Lee HJ; Choi SY; Hong SH
    Cell Physiol Biochem; 2018; 50(5):1869-1881. PubMed ID: 30396177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. STC2 promotes head and neck squamous cell carcinoma metastasis through modulating the PI3K/AKT/Snail signaling.
    Yang S; Ji Q; Chang B; Wang Y; Zhu Y; Li D; Huang C; Wang Y; Sun G; Zhang L; Guan Q; Xiang J; Wei W; Lu Z; Liao T; Meng J; Wang Z; Ma B; Zhou L; Wang Y; Yang G
    Oncotarget; 2017 Jan; 8(4):5976-5991. PubMed ID: 27863406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxytocin inhibits head and neck squamous cell carcinoma cell migration by early growth response-1 upregulation.
    Kim J; Kang SM; Lee HJ; Choi SY; Hong SH
    Anticancer Drugs; 2017 Jul; 28(6):613-622. PubMed ID: 28452807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lupeol suppresses cisplatin-induced nuclear factor-kappaB activation in head and neck squamous cell carcinoma and inhibits local invasion and nodal metastasis in an orthotopic nude mouse model.
    Lee TK; Poon RT; Wo JY; Ma S; Guan XY; Myers JN; Altevogt P; Yuen AP
    Cancer Res; 2007 Sep; 67(18):8800-9. PubMed ID: 17875721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.